| Product Code: ETC7656028 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Microrna Mirna Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Microrna Mirna Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Microrna Mirna Market - Industry Life Cycle |
3.4 Israel Microrna Mirna Market - Porter's Five Forces |
3.5 Israel Microrna Mirna Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Israel Microrna Mirna Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Israel Microrna Mirna Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Israel leading to higher demand for miRNA-based diagnostics and therapeutics |
4.2.2 Growing investments in research and development of miRNA technologies in Israel |
4.2.3 Favorable government initiatives and regulations supporting the development and commercialization of miRNA products in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for miRNA-based products in Israel |
4.3.2 Limited awareness and understanding of miRNA technologies among healthcare professionals and patients in the market |
5 Israel Microrna Mirna Market Trends |
6 Israel Microrna Mirna Market, By Types |
6.1 Israel Microrna Mirna Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Israel Microrna Mirna Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Israel Microrna Mirna Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.4 Israel Microrna Mirna Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.5 Israel Microrna Mirna Market Revenues & Volume, By Immunological Disorder, 2021- 2031F |
6.1.6 Israel Microrna Mirna Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.1.7 Israel Microrna Mirna Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.1.8 Israel Microrna Mirna Market Revenues & Volume, By Other, 2021- 2031F |
6.2 Israel Microrna Mirna Market, By End-Use |
6.2.1 Overview and Analysis |
6.2.2 Israel Microrna Mirna Market Revenues & Volume, By Biotechnology, 2021- 2031F |
6.2.3 Israel Microrna Mirna Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.2.4 Israel Microrna Mirna Market Revenues & Volume, By Academic, 2021- 2031F |
6.2.5 Israel Microrna Mirna Market Revenues & Volume, By Government Research Institutes, 2021- 2031F |
6.2.6 Israel Microrna Mirna Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Microrna Mirna Market Import-Export Trade Statistics |
7.1 Israel Microrna Mirna Market Export to Major Countries |
7.2 Israel Microrna Mirna Market Imports from Major Countries |
8 Israel Microrna Mirna Market Key Performance Indicators |
8.1 Number of research collaborations between Israeli biotech companies and academic institutions focusing on miRNA technologies |
8.2 Percentage increase in funding allocated to miRNA research and development projects in Israel |
8.3 Adoption rate of miRNA-based diagnostics and therapeutics in clinical settings in the country |
9 Israel Microrna Mirna Market - Opportunity Assessment |
9.1 Israel Microrna Mirna Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Israel Microrna Mirna Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Israel Microrna Mirna Market - Competitive Landscape |
10.1 Israel Microrna Mirna Market Revenue Share, By Companies, 2024 |
10.2 Israel Microrna Mirna Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here